Treatment options for heart failure in individuals with overweight or obesity: a review

Informa UK Limited

Paschalis Karakasis , Efstratios Karagiannidis , Nikolaos Fragakis , Theocharis Koufakis , Christos Kofos , Athina Nasoufidou , Aleksandra Klisic , Djordje S. Popovic , Panagiotis Stachteas , Dimitrios Patoulias

Preuzmite dokument

2025

Informa UK Limited

Treatment options for heart failure in individuals with overweight or obesity: a review

Preuzmite dokument 2025 Paschalis Karakasis , Efstratios Karagiannidis , Nikolaos Fragakis , Theocharis Koufakis , Christos Kofos , Athina Nasoufidou , Aleksandra Klisic , Djordje S. Popovic , Panagiotis Stachteas , Dimitrios Patoulias

Wiley

Sodium‐glucose cotransporter 2 inhibitors and outcomes in transthyretin amyloid cardiomyopathy: Systematic review and meta‐analysis

AbstractBackgroundTransthyretin amyloid cardiomyopathy (ATTR‐CM) commonly leads to heart failure but has traditionally been an exclusion criterion in randomized clinical trials (RCTs) of sodium‐glucose cotransporter 2 inhibitors (SGLT2i); therefore, the effects of these drugs in this population remain undocumented. In light of recent studies, this meta‐analysis aimed to investigate the effect of SGLT2i on the prognosis of patients with ATTR‐CM.MethodsA comprehensive search of Medline, Scopus, and...

Preuzmite dokument 2025 Paschalis Karakasis , Panagiotis Theofilis , Manfredi Rizzo , Nikolaos Fragakis , Panayotis K Vlachakis , Aleksandra Klisic , Dimitrios Patoulias , Art Schuermans

Bentham Science Publishers Ltd.

Therapeutic Potential of Sodium-glucose Co-transporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists for Patients with Acute Coronary Syndrome: A Review of Clinical Evidence

: Atherosclerotic Cardiovascular Disease (ASCVD) is still one of the leading causes of death globally, with Coronary Artery Disease (CAD) being the most prevalent form of ASCVD. Patients with type 2 Diabetes Mellitus (DM) experience an increased risk for ASCVD during the disease course, with CAD being the most common cause of death among affected individuals, resulting in shorter life expectancy and increased morbidity among survivors. Recently, 2 novel classes of anti-diabetic drugs, namely Sodium-Glucose...

Preuzmite dokument 2024 Paschalis Karakasis , Manfredi Rizzo , Nikolaos Fragakis , Theocharis Koufakis , Michael Doumas , Aleksandra Klisic , Dimitrios Patoulias , George Kassimis

Wiley

Effects of glucagon‐like peptide‐1 receptor agonists on glycated haemoglobin and continuous glucose monitoring metrics as adjunctive therapy to insulin in adults with type 1 diabetes: A meta‐analysis of randomized controlled trials

AbstractAimsTo conduct a meta‐analysis of randomized controlled trials (RCTs) to evaluate the effect of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) on glycated haemoglobin (HbA1c) and continuous glucose monitoring (CGM) metrics as an adjunct to insulin therapy in adults with type 1 diabetes mellitus (T1D).MethodsA systematic literature search was conducted through Medline (via PubMed), Cochrane Library, and Google Scholar up to 27 May 2024. Dual‐independent study selection, data extraction,...

Preuzmite dokument 2024 Paschalis Karakasis , Fotios Barkas , Theocharis Koufakis , Michael Doumas , Nikolaos Papanas , Aleksandra Klisic , Djordje S. Popovic , Milena Mitrovic , Dimitrios Patoulias

Mary Ann Liebert Inc

Are Oxidative Stress Biomarkers Reliable Part of Multimarker Panel in Female Patients with Type 2 Diabetes Mellitus?

Preuzmite dokument 2024 Paschalis Karakasis , Amirmohammad Khalaji , Aleksandra Klisic , Ana Ninic , Dimitrios Patoulias